Cargando…
Genome‐wide association study: Exploring the genetic basis for responsiveness to ketogenic dietary therapies for drug‐resistant epilepsy
OBJECTIVE: With the exception of specific metabolic disorders, predictors of response to ketogenic dietary therapies (KDTs) are unknown. We aimed to determine whether common variation across the genome influences the response to KDT for epilepsy. METHODS: We genotyped individuals who were negative f...
Autores principales: | Schoeler, Natasha E., Leu, Costin, Balestrini, Simona, Mudge, Jonathan M., Steward, Charles A., Frankish, Adam, Leung, Mary‐Anne, Mackay, Mark, Scheffer, Ingrid, Williams, Ruth, Sander, Josemir W., Cross, J. Helen, Sisodiya, Sanjay M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099477/ https://www.ncbi.nlm.nih.gov/pubmed/30009487 http://dx.doi.org/10.1111/epi.14516 |
Ejemplares similares
-
Variants in KCNJ11 and BAD do not predict response to ketogenic dietary therapies for epilepsy
por: Schoeler, Natasha E., et al.
Publicado: (2015) -
Biochemical assessment of patients following ketogenic diets for epilepsy: Current practice in the UK and Ireland
por: Schoeler, Natasha E., et al.
Publicado: (2019) -
Pharmacogenomics in epilepsy
por: Balestrini, Simona, et al.
Publicado: (2018) -
Genome-wide Polygenic Burden of Rare Deleterious Variants in Sudden Unexpected Death in Epilepsy
por: Leu, Costin, et al.
Publicado: (2015) -
Rare and Complex Epilepsies from Childhood to Adulthood: Requirements for Separate Management or Scope for a Lifespan Holistic Approach?
por: Balestrini, Simona, et al.
Publicado: (2021)